Kang B, Kim Y, Park TJ, Kang HY
Lack of adipocyte AMPK exacerbates insulin resistance and hepatic steatosis through brown and beige adipose tissue function
La formulazione migliorata del 2025 Nel 2025 Novo Nordisk ha introdotto una nuova formulazione di Rybelsus, denominata tecnicamente R2, con eccipienti modificati che raddoppiano la biodisponibilit dallintervallo 0,41% della formulazione originale all12% della nuova (FDA, 2025)
For patients looking to support their health, fitness, and overall well-being, Ipamorelin is one of the more commonly discussed options within peptide therapy
Study: Real-world evaluation of clinical outcomes in Dutch patients with type 2 diabetes treated with oral semaglutide: A retrospective, observational cohort study using the PHARMO data network
Gut Microbiome Effects Research suggests compounds such as 5-Amino-1MQ may alter the gut microbiome in models